S 483 · 119th Congress
Responsibility in Drug Advertising Act of 2025
This bill puts a three-year pause on drug companies advertising new medications directly to consumers. That means you won't see ads on social media, TV, or other platforms promoting a brand-new drug during its first three years on the market. The idea is to give the FDA time to monitor how the drug actually performs…
- Sponsor
- King, Angus S., Jr. (I-Maine)
- Introduced
- 2025-02-06
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍